Oncofetal protein, IMP-3, a potential marker for prediction of postoperative peritoneal dissemination in gastric adenocarcinoma

Journal of Surgical Oncology

Volumn 105, Issue 8, 2012, Pages 780-785

  Okada, Kaoru ^a   Fujiwara, Yoshiyuki ^a   Nakamura, Yurika ^a   Takiguchi, Shuji ^a   Nakajima, Kiyokazu ^a   Miyata, Hiroshi ^a   Yamasaki, Makoto ^a   Kurokawa, Yukinori ^a   Takahashi, Tsuyoshi ^a   Mori, Masaki ^a   Doki, Yuichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

gastric cancer; IMP 3; peritoneal dissemination; RT PCR

Indexed keywords

INSULIN LIKE GROWTH FACTOR II MESSENGER RNA BINDING PROTEIN 3; ONCOFETAL ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PERITONEUM LAVAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; RECURRENCE FREE SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LAPAROTOMY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PERITONEAL LAVAGE; PERITONEAL NEOPLASMS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-BINDING PROTEINS; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84861098583     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.22108     Document Type: Article

References (36)

1. Nielsen J, Christiansen J, Lykke-Andersen J, et al.: A Family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol 1999; 19: 1262-1270. (Pubitemid 29046868)
2. Mueller-Pillasch F, Pohl B, Wilda M, et al.: Expression of the highly conserved RNA binding protein KOC in embryogenesis. Mech Dev 1999; 88: 95-99. (Pubitemid 29467415)
3. Nielsen FC, Nielsen J, Christiansen J,: A family of IGF-II mRNA binding proteins(IMP) involved in RNA trafficking. Scand J Clin Lab Invest 2001; 61: 93-99. (Pubitemid 33043632)
4. Schaeffer D, Owen D, Lim H, et al.: Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival. BMC Cancer 2010; 10: 59.
5. Wang T, Fan L, Watanabe Y, et al.: L523S, an RNA-binding protein as a potential therapeutic target for lung cancer. Br J Cancer 2003; 88: 887-894. (Pubitemid 36520876)
6. Dawei L, Dongwang Y, Huaamei T, et al.: IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis. Ann Surg Oncol 2009; 16: 3499-3506.
7. Zheng W, Yi X, Fadare O, et al.: The oncofetal protein IMP3: A novel biomarker for endometrial serous carcinoma. Am J Surg Pathol 2008; 32: 304-315. (Pubitemid 351172146)
8. Köbel M, Xu H, Bourne PA, et al.: IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype. Mod Pathol 2009; 22: 469-475.
9. Jiang Z, Chu PG, Woda BA, et al.: Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: A retrospective study. Lancet Oncol 2006; 7: 556-564. (Pubitemid 43923666)
10. Jeng YM, Chang CC, Hu FC, et al.: RNA-binding protein insulin-like growth factor II mRNA-binding protein3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma. Hepatology 2008; 48: 1118-1127.
11. Jeng YM, Wang TH, Lu SH, et al.: Prognostic significance of insulin-like growth factor II mRNA-binding protein 3 expression in gastric adenocarcinoma. Br J Surg 2009; 96: 66-73.
12. Ferlay J, Shin HR, Bray F, et al.: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
13. Parkin DM, Bray F, Ferlay J, et al.: Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108. (Pubitemid 40372904)
14. Dupont JB, Jr., Lee JR, Burton GR, et al.: Adenocarcinoma of the stomach: Review of 1,497 cases. Cancer 1978; 41: 941-947. (Pubitemid 8313231)
15. Yamada E, Miyaishi S, Nakazato H, et al.: The surgical treatment of cancer of the stomach. Int Surg 1980; 65: 387-399. (Pubitemid 12115232)
16. Yoo CH, Noh SH, Shin DW, et al.: Recurrence following curative resection for gastric carcinoma. Br J Surg 2000; 87: 236-242. (Pubitemid 30088655)
17. Bando E, Yonemura Y, Takeshita Y, et al.: Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma. Am J Surg 1999; 178: 256-262. (Pubitemid 29475109)
18. Benevolo M,: Diagnostic and prognostic value of peritoneal immunocytology in gastric cancer. J Clin Oncol 1998; 16: 3406-3411. (Pubitemid 28481640)
19. Koga S, Kaibara N, Iitsuka Y, et al.: Prognostic significance of intra-peritoneal free cancer cells in gastric cancer patients. J Cancer Res Clin Oncol 1984; 108: 236-238. (Pubitemid 14057507)
20. Noura S, Yamamoto H, Ohnishi T, et al.: Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry. J Clin Oncol 2002; 20: 4232-4241. (Pubitemid 35191026)
21. Yoshioka S, Fujiwara Y, Sugita Y, et al.: Real-time rapid reverse transcriptase-polymerase chain reaction for intraoperative diagnosis of lymph node micrometastasis: Clinical application for cervical lymph node dissection in esophageal cancers. Surgery 2002; 132: 34-40. (Pubitemid 34787819)
22. Okada Y, Fujiwara Y, Yamamoto H, et al.: Genetic detection of lymph node micrometastases in patients with gastric carcinoma by multiple-marker reverse transcriptase-polymerase chain reaction assay. Cancer 2001; 92: 2056-2064. (Pubitemid 32973314)
23. Sugita Y, Fujiwara Y, Taniguchi H, et al.: Quantitative molecular diagnosis of peritoneal lavage fluid for prediction of peritoneal recurrence in gastric cancer. Int J Oncol 2003; 23: 1419-1423.
24. Majima T, Ichikura T, Mochizuki H,: Prognostic significance of the cytologic features of free cancer cells in the peritoneal cavity of patients with gastric cancer. Surg Today 2002; 32: 35-39. (Pubitemid 34119044)
25. Nakanishi H, Kodera Y, Torii A, et al.: Detection of carcinoembryonic antigen-expressing free tumor cells in peritoneal washes from patients with gastric carcinoma by polymerase chain reaction. Jpn J Cancer Res 1997; 88: 687-692. (Pubitemid 27394053)
26. Nakanishi H, Kodera Y, Yamamura Y, et al.: Rapid quantitative detection of carcinoembryonic antigen-expressing free tumor cells in the peritoneal cavity of gastric-cancer patients with real-time RT-PCR on the LightCycler. Int J Cancer 2000; 89: 411-417.
27. Yonemura Y, Fujimura T, Ninomiya I, et al.: Prediction of peritoneal micrometastasis by peritoneal lavaged cytology and reverse transcriptase- polymerase chain reaction for matrix metalloproteinase-7 mRNA. Clin Cancer Res 2001; 7: 1647-1653. (Pubitemid 32708631)
28. Schmidt P, Thiele M, Rudroff C, et al.: Detection of tumor cells in peritoneal lavages from patients with gastrointestinal cancer by multiplex reverse transcriptase PCR. Hepatogastroenterology 2001; 48: 1675-1679. (Pubitemid 34003502)
29. Kodera Y, Nakanishi H, Yamamura Y, et al.: Prognostic value and clinical implications of disseminated cancer cells in the peritoneal cavity detected by reverse transcriptase-polymerase chain reaction and cytology. Int J Cancer 1998; 79: 429-433. (Pubitemid 28359744)
30. Kodera Y, Nakanishi H, Yamamura Y, et al.: Quantitative detection of disseminated free cancer in peritoneal washes with real-time reverse transcriptase polymerase chain reaction. Ann Surg 2002; 235: 499-506.
31. Japanese Gastric Cancer A. Japanese classification of gastric carcinoma-2nd English edition. Gastric Cancer 1998; 1: 10-24.
32. Liao B, Hu Y, Herrick DJ, et al.: The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells. J Biol Chem 2005; 280: 18517-18524. (Pubitemid 41389102)
33. Mueller-Pillasch F, Lacher U, Wallrapp C, et al.: Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene 1997; 32: 379-388.
34. Suda T, Tsunoda T, Daigo Y, et al.: Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy. Cancer Sci 2007; 98: 1803-1808. (Pubitemid 47489730)
35. Kono K, Mizukami Y, Daigo Y, et al.: Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer. Cancer Sci 2009; 100: 1502-1509.
36. Kodera Y, Nakanishi H, Ito S, et al.: Prognostic significance of intraperitoneal cancer cells in gastric carcinoma: Detection of cytokeratin 20 mRNA in peritoneal washes, in addition to detection of carcinoembryonic antigen. Gastric Cancer 2005; 8: 142-148. (Pubitemid 41176092)